![John Stuelpnagel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Stuelpnagel
Voorzitter bij
10X GENOMICS, INC.
Vermogen: 220 M $ op 30-09-2026
Profiel
John R. Stuelpnagel is een ondernemer en zakenman die Illumina, Inc., Fabric Genomics, Inc. en Ariosa Diagnostics, Inc. heeft opgericht en aan het hoofd heeft gestaan van 6 verschillende bedrijven. Hij is voorzitter bij 10X Genomics, Inc., voorzitter bij Fabric Genomics, Inc., voorzitter bij Inscripta, Inc. en voorzitter bij Element Biosciences, Inc. John R. Stuelpnagel zit ook in de Raad van Bestuur van Federation Bio, Inc. en Encoded Therapeutics, Inc. In het verleden bekleedde Dr. Stuelpnagel de functie van Chief Operating Officer & Director bij Illumina, Inc., Associate bij CW Group, Inc., BRD bij Sequenta, Inc. en Uitvoerend Voorzitter van Ariosa Diagnostics, Inc. Hij behaalde een doctoraat en een bachelor diploma aan de University of California, Davis en een MBA aan de University of California, Los Angeles.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
10X GENOMICS INC 10,47% | 31-03-2026 | 2.105.736 ( 10,47% ) | 190 M $ | 30-09-2026 |
| 03-09-2026 | 328.436 ( 0,27% ) | 30 M $ | 30-09-2026 |
Actieve functies van John Stuelpnagel
| Bedrijven | Functie | Begin |
|---|---|---|
| 10X GENOMICS, INC. | Voorzitter | 01-08-2013 |
Fabric Genomics, Inc.
 Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Oprichter | - |
Inscripta, Inc.
 Inscripta, Inc. BiotechnologyHealth Technology Develops digital genome engineering solutions | Voorzitter | 01-04-2017 |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops and manufactures disease-modifying gene therapies for pediatric central nervous system | Directeur/Bestuurslid | 01-05-2017 |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Directeur/Bestuurslid | 01-06-2020 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Consultant / Adviseur | 01-01-1998 |
Eerdere bekende functies van John Stuelpnagel
| Bedrijven | Functie | Einde |
|---|---|---|
Element Biosciences, Inc.
 Element Biosciences, Inc. Medical SpecialtiesHealth Technology Develops single-cell and spatial multiomics sequencing & reagent kits and related software solutions | Voorzitter | 01-01-2023 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur/Bestuurslid | 01-11-2017 |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Oprichter | 01-01-2015 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van John Stuelpnagel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
82
Eerstegraads connecties
14
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Sequenta, Inc.
 Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
10X Genomics, Inc.
 10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Technology Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Health Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Inscripta, Inc.
Inscripta, Inc. BiotechnologyHealth Technology Develops digital genome engineering solutions | Health Technology |
Federation Bio, Inc.
Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Health Technology |
Element Biosciences, Inc.
Element Biosciences, Inc. Medical SpecialtiesHealth Technology Develops single-cell and spatial multiomics sequencing & reagent kits and related software solutions | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops and manufactures disease-modifying gene therapies for pediatric central nervous system | Health Technology |
